Combined antifungal therapy in a murine infection by Candida glabrata

Marçal Mariné1, Carolina Serena, F Javier Pastor

  • 1Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Carrer Sant Llorenç 21, 43201, Reus, Spain.

Abstract

Insights

New antifungal drug combinations were tested for disseminated Candida glabrata infections. Micafungin plus amphotericin B showed the most promise in reducing fungal burden and improving survival in a murine model.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Disseminated Candida glabrata infections pose a significant therapeutic challenge.
  • Current antifungal treatments are often ineffective for non-responsive cases.

Purpose of the Study:

  • To evaluate novel antifungal drug combinations for treating disseminated C. glabrata infections.
  • To identify effective treatment strategies for drug-resistant fungal infections.

Main Methods:

  • A murine model of neutropenia was established using cyclophosphamide and 5-fluorouracil.
  • Mice were infected with Candida glabrata, and the efficacy of drug combinations (micafungin with amphotericin B, fluconazole, or flucytosine; amphotericin B with fluconazole) was assessed.
  • Survival rates and fungal tissue burden in organs were measured.

Main Results:

  • Micafungin combined with amphotericin B demonstrated the greatest efficacy in reducing fungal tissue burden.
  • Specific combinations of micafungin and amphotericin B prolonged survival and showed synergistic effects in reducing fungal load in the spleen and kidney.
  • Amphotericin B at 1.5 mg/kg combined with varying doses of micafungin effectively reduced tissue burden.

Conclusions:

  • Amphotericin B in combination with micafungin is a promising therapeutic strategy for disseminated C. glabrata infections.
  • Combination therapy offers improved outcomes compared to monotherapy for resistant fungal infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...